Comparison of mupirocin and erythromycin in the treatment of impetigo.
Britton
J W
JW
Department of Pediatrics, Naval Hospital, Portsmouth, Virginia 23708-5000.
Fajardo
J E
JE
Krafte-Jacobs
B
B
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004311:Double-Blind Method; D004917:Erythromycin / Q000009:adverse effects / Q000627:therapeutic use*; D005227:Fatty Acids / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007169:Impetigo / Q000188:drug therapy*; D007223:Infant; D008297:Male; D016712:Mupirocin
D000900:Anti-Bacterial Agents; D005227:Fatty Acids; D004917:Erythromycin; D016712:Mupirocin